featured
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
J Am Coll Cardiol 2021 Jul 06;78(1)14-23, JW Eikelboom, DL Bhatt, KAA Fox, J Bosch, SJ Connolly, SS Anand, A Avezum, SD Berkowitz, KRH Branch, GR Dagenais, C Félix, TJ Guzik, RG Hart, AP Maggioni, E Muehlhofer, M Sharma, O Shestakovska, S YusufFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.